We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

143 hedge funds and large institutions have $289M invested in SANGAMO THERAPEUTICS INC in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

287% more call options, than puts

Call options by funds: $4.73M | Put options by funds: $1.22M

37% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 38

11% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 19

1% more funds holding

Funds holding: 141143 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

35% less capital invested

Capital invested by funds: $448M → $289M (-$158M)

Holders
143
Holders Change
+2
Holders Change %
+1.42%
% of All Funds
3.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
52
Reduced
38
Closed
19
Calls
$4.73M
Puts
$1.22M
Net Calls
+$3.5M
Net Calls Change
-$21.8M
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
51
Princeton Capital Management Inc
New Jersey
$753K -$18K -3,000 -2%
PP
52
PDT Partners
New York
$681K +$676K +112,600 New
Swiss National Bank
53
Swiss National Bank
Switzerland
$663K +$128K +21,400 +23%
NI
54
Numeric Investors
Massachusetts
$656K -$243K -40,500 -27%
Dimensional Fund Advisors
55
Dimensional Fund Advisors
Texas
$600K +$596K +99,210 New
AIC
56
AWM Investment Company
New York
$558K
AllianceBernstein
57
AllianceBernstein
Tennessee
$553K -$61.2K -10,200 -10%
TC
58
TFS Capital
Pennsylvania
$550K +$546K +90,971 New
T. Rowe Price Associates
59
T. Rowe Price Associates
Maryland
$488K +$106K +17,600 +28%
PCM
60
Piermont Capital Management
Missouri
$487K +$484K +80,569 New
SIM
61
Spark Investment Management
New York
$472K +$469K +78,100 New
IHM
62
Iguana Healthcare Management
New York
$454K -$751K -125,000 -63%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$438K +$2.52K +420 +0.6%
KeyBank National Association
64
KeyBank National Association
Ohio
$436K +$32.8K +5,465 +8%
Goldman Sachs
65
Goldman Sachs
New York
$414K -$652K -108,533 -61%
BG
66
BlackRock Group
United Kingdom
$405K +$54.6K +9,095 +16%
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$384K
WS
68
Wedbush Securities
California
$376K -$1.8K -300 -0.5%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$369K
ProShare Advisors
70
ProShare Advisors
Maryland
$367K -$35.2K -5,855 -9%
ARTA
71
A.R.T. Advisors
New York
$357K +$42.6K +7,100 +14%
Citigroup
72
Citigroup
New York
$327K +$227K +37,778 +231%
FSA
73
Franklin Street Advisors
North Carolina
$324K
GT
74
Glenmede Trust
Pennsylvania
$309K
WC
75
Wexford Capital
Florida
$299K +$297K +49,432 New

SGMO Hedge Fund Activity: Q1 2016 in Review

143 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q1 2016, worth a combined $289M — down 35% from $448M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new SGMO positions and 19 closed out — a net gain of 2 holders — while 52 added to existing stakes and 38 trimmed.

The largest buyer was Bank of New York Mellon, adding an estimated $8.81M. The largest seller was Millennium Management, cutting an estimated $9.1M.

  • 143 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q1 2016, up from 141 in Q4 2015.
  • Funds reported $289M of SANGAMO THERAPEUTICS INC stock for Q1 2016, down 35% quarter-over-quarter.
  • 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q1 2016 and 19 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q1 2016 was Bank of New York Mellon, an estimated $8.81M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q1 2016 was Millennium Management, an estimated $9.1M sold.

Based on aggregated 13F filings for Q1 2016.